Neuropeptides and microglial activation in inflammation, pain, and neurodegenerative diseases L Carniglia, D Ramírez, D Durand, J Saba, J Turati, C Caruso, ... Mediators of inflammation 2017 (1), 5048616, 2017 | 239 | 2017 |
Memantine agonist action at dopamine D2High receptors P Seeman, C Caruso, M Lasaga Synapse 62 (2), 149-153, 2008 | 150 | 2008 |
Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-γ in astrocytes C Caruso, D Durand, HB Schiöth, R Rey, A Seilicovich, M Lasaga Endocrinology 148 (10), 4918-4926, 2007 | 113 | 2007 |
Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP–Protein kinase A pathway C Caruso, L Carniglia, D Durand, PV Gonzalez, TN Scimonelli, M Lasaga Molecular and cellular endocrinology 348 (1), 47-54, 2012 | 89 | 2012 |
Role of α-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation M Lasaga, L Debeljuk, D Durand, TN Scimonelli, C Caruso Peptides 29 (10), 1825-1835, 2008 | 81 | 2008 |
Role of metabotropic glutamate receptors in the control of neuroendocrine function D Durand, M Pampillo, C Caruso, M Lasaga Neuropharmacology 55 (4), 577-583, 2008 | 70 | 2008 |
Molecular mechanisms involved in interleukin 1-beta (IL-1β)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (α-MSH) P Gonzalez, I Machado, A Vilcaes, C Caruso, GA Roth, H Schiöth, ... Brain, behavior, and immunity 34, 141-150, 2013 | 64 | 2013 |
Effect of NDP-α-MSH on PPAR-γ and–β expression and anti-inflammatory cytokine release in rat astrocytes and microglia L Carniglia, D Durand, C Caruso, M Lasaga PLoS One 8 (2), e57313, 2013 | 60 | 2013 |
Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats C Caruso, C Mohn, AL Karara, V Rettori, H Watanobe, HB Schiöth, ... Neuroendocrinology 79 (5), 278-286, 2004 | 58 | 2004 |
Astrocyte truncated tropomyosin receptor kinase B mediates brain‐derived neurotrophic factor anti‐apoptotic effect leading to neuroprotection J Saba, J Turati, D Ramírez, L Carniglia, D Durand, M Lasaga, C Caruso Journal of neurochemistry 146 (6), 686-702, 2018 | 56* | 2018 |
mGlu3 receptor and astrocytes: partners in neuroprotection D Durand, L Carniglia, C Caruso, M Lasaga Neuropharmacology 66, 1-11, 2013 | 49 | 2013 |
Astrocytes: new targets of melanocortin 4 receptor actions C Caruso, L Carniglia, D Durand, TN Scimonelli, M Lasaga Journal of molecular endocrinology 51 (2), R33-R50, 2013 | 46 | 2013 |
Lipopolysaccharide-and tumor necrosis factor-α-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis A De Laurentiis, D Pisera, C Caruso, M Candolfi, C Mohn, V Rettori, ... Neuroimmunomodulation 10 (1), 30-39, 2002 | 44 | 2002 |
Glutamate induces apoptosis in anterior pituitary cells through group II metabotropic glutamate receptor activation C Caruso, MC Bottino, M Pampillo, D Pisera, G Jaita, B Duvilanski, ... Endocrinology 145 (10), 4677-4684, 2004 | 43 | 2004 |
Astroglial mGlu3 receptors promote alpha-secretase-mediated amyloid precursor protein cleavage D Durand, L Carniglia, J Beauquis, C Caruso, F Saravia, M Lasaga Neuropharmacology 79, 180-189, 2014 | 41 | 2014 |
Reduced cAMP, Akt activation and p65-c-Rel dimerization: mechanisms involved in the protective effects of mGluR3 agonists in cultured astrocytes D Durand, L Carniglia, C Caruso, M Lasaga PloS one 6 (7), e22235, 2011 | 41 | 2011 |
Melanocortin 4 receptor activates ERK-cFos pathway to increase brain-derived neurotrophic factor expression in rat astrocytes and hypothalamus D Ramírez, J Saba, L Carniglia, D Durand, M Lasaga, C Caruso Molecular and cellular endocrinology 411, 28-37, 2015 | 37 | 2015 |
Neuroinflammation in Huntington’s disease: a starring role for astrocyte and microglia J Saba, FL Couselo, J Bruno, L Carniglia, D Durand, M Lasaga, C Caruso Current Neuropharmacology 20 (6), 1116, 2022 | 36 | 2022 |
Dopamine partial agonist actions of the glutamate receptor agonists LY 354,740 and LY 379,268 P Seeman, C Caruso, M Lasaga Synapse 62 (2), 154-158, 2008 | 34 | 2008 |
Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors D Durand, L Carniglia, J Turati, D Ramírez, J Saba, C Caruso, M Lasaga Neuropharmacology 123, 274-286, 2017 | 33 | 2017 |